A comprehensive review led by cancer researchers at UNSW found vaping is likely to cause lung and oral cancer – even before long-term studies can confirm the exact risk.

The model organ for this research project is the best pediatric brain tumor model developed so far and can be used to test new drugs. The results of the project, conducted by the University of Trento with Bambino Gesù Children's Hospital in Rome, were published in the Nature Protocols. The result is expected to have a positive impact on the international scientific and clinical community because it opens up unexplored possibilities. The research focuses on ependymoma and medulloblastoma, which are among the most common and aggressive malignant pediatric brain tumors.

Acute myeloid leukemia (AML) remains one of the most difficult blood cancers to treat. Although drug combinations are often more effective than single agents, their true mechanisms of action have been poorly understood. A new study introduces CoPISA – the Combinatorial Proteome Integral Solubility/Stability Alteration analysis, a powerful high‑throughput proteomics workflow that uncovers how drug combinations reshape the soluble proteome in ways that single drugs cannot.

The study "Diagnostic Timing and Ovarian Cancer Survival in North Carolina" has been published in the latest issue of JAMA Network Open. Led by a team of UNC researchers, this study explored the relationship between survival and how quickly patients are diagnosed with ovarian cancer.

About The Study: This study estimated income losses from the individual perspective in the 10 years following hospital diagnosis of depression, alcohol use disorder, stroke, and breast cancer from 2000 to 2023 in Denmark. The researchers found that (1) income losses following mental disorder diagnoses were larger than those for physical conditions, though all evaluated diseases led to substantive loss; (2) average losses grew in years following diagnosis, particularly among individuals younger than 40 and those in school, suggesting accumulating disadvantage; and (3) even those outside of the workforce at the time of hospital diagnosis experienced sustained future income loss.